3rd Annual Women Leaders in IO Luncheon
IO360° is proud to present the third annual Women Leaders in IO Luncheon. This is a networking event specifically for women in Immuno-Oncology, designed to empower and elevate women's leadership and career growth within the field.
The luncheon will take place Monday, March 24, 2025 from 12:30 PM - 01:45 PM and will include a panel on the below. Open Q&A to follow. Attendees must be registered to attend the IO360° Summit, pre-registration for the luncheon also required.
Empowering Women Leaders in Immuno-Oncology:
Overcoming Challenges and Building Influence
This session will uncover strategies for women in Immuno-Oncology to excel in leadership roles, tackle industry-specific challenges, and amplify their voices in a rapidly evolving field. Attendees will leave with actionable insights to build resilience, establish credibility, and foster supportive networks that drive success.
Key Topics Include:
- Overcoming setbacks and maintaining momentum in high-stakes environments
- Establishing influence and advocating for leadership opportunities in IO
- Navigating complex conversations and ensuring women’s visibility in IO leadership
- Leveraging mentorship, sponsorship, and networks for career growth
- Best practices for fostering inclusive environments and elevating women’s voices in Immuno-Oncology
Panelists Include:
.jpeg)
Christine Ward, PhD
VP, Head of Translational Medicine - Therapeutics & Oncology Development
Moderna
Helena Chaye, PhD, JD
CEO
Kalivir Immunotherapeutics
Rachel Humphrey, MD
President and Founding CEO
Normunity
Randi Isaacs, MD
Chief Medical Officer
Werewolf Therapeutics
.jpeg)
Ashley Lakner
Head, Oncology Discovery - pRED Oncology
Roche